Traditional Chinese medicinal preparation for treating decompensated cirrhosis

Abstract

The invention discloses a traditional Chinese medicinal preparation for treating decompensated cirrhosis, and relates to a traditional Chinese medicinal preparation; the traditional Chinese medicinal preparation for treating decompensated cirrhosis is characterized by consisting of the following traditional Chinese medicinal raw materials in parts by weight: 15-50 parts of radix et rhizoma malloti apeltae, 10-50 parts of radix rhodomyrti, 15-50 parts of radix millettiae speciosae, 10-50 parts of root bark or stem bark of aralia chinensis linn., 15-50 parts of root of beautiful phyllodium, 15-50 parts of root of sachalin raspberry, 15-50 parts of radix cudraniae, 15-50 parts of root of rabdosia ternifolia hara, 10-50 parts of herba verbenae, 15-50 parts of roughhaired holly root and 10-20 parts of stem and leaf of Hongkong pavetta; and the traditional Chinese medicinal preparation can be reasonably prepared into such dosage forms as decoction, mixture, syrup, tablets, capsules and the like. The medicine disclosed by the invention has relatively good anti-inflammatory, antiviral and anti-fibrosis functions on liver inflammation; and the medicine can be used for effectively treating the liver inflammation of the decompensated cirrhosis disease and preventing the development from liver inflammation to liver cirrhosis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for treating compensated liver cirrhosis. Background technique [0002] On May 15, 2015, the United Nations News Network reported that the World Health Organization announced that there are about 90 million chronic hepatitis B patients in China. Clinical medicine has found that 25%-30% of chronic hepatitis B will develop into liver cirrhosis, and 15% of liver cirrhosis can develop into compensated liver cirrhosis. The 5-year survival rate of patients with compensated liver cirrhosis is 55%. Liver cirrhosis is a disease that has seriously endangered people's health. [0003] Compensated liver cirrhosis is a chronic, progressive, diffuse liver lesion caused by different etiologies acting on the liver for a long time, mainly due to the diffuse proliferation of liver fibrous tissue on the basis of extensive necrosis of liver cel...

AI Technical Summary

Problems solved by technology

"Anti-inflammation, anti-virus, preventing the liver from inflammation to cirrhosis" is the key to the treatment of compensated liver cirrhosis. At present, Western medicine has no exact treatment methods and drugs for compensated liver cirrhosis; In terms of treatment experience, there is still a gap in the research and development of Chinese patent medicines that "anti-inflammation, anti-virus, and prevent liver from developing from inflammation to hardening"